Zai Lab Limited
ZLABDrugs in Pipeline
10
Phase 3 Programs
4
Upcoming Catalysts
2
Next Catalyst
Aug 6, 2026
28dMarket Overview
Stock performance and key metrics
3 upcoming, 0 past
How ZLAB's past catalysts played out
ZL-1310
Solid Tumors
Omadacycline
Community-acquired Bacterial Pneumonia
ZL-1109 (VRDN-003)
Thyroid Eye Disease (TED)
Investigator's Choice of Therapy
Small-cell Lung Cancer
DCC-2618
Gastrointestinal Stromal Tumors
ZL-2306(Niraparib）
Ovarian Cancer
ZL-3101
Eczema
Brivanib 800 mg, QD
Hepatocellular Carcinoma (HCC)
ZL-1102 1% w/w gel BID for 16 weeks
Plaque Psoriasis
Ripretinib
Gastrointestinal Stromal Tumor(GIST)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ZL-1310 | Phase 3 | Solid Tumors | - | - |
Omadacycline | Phase 3 | Community-acquired Bacterial Pneumonia | - | - |
ZL-1109 (VRDN-003) | Phase 3 | Thyroid Eye Disease (TED) | - | - |
Investigator's Choice of Therapy | Phase 3 | Small-cell Lung Cancer | - | - |
DCC-2618 | Phase 2 | Gastrointestinal Stromal Tumors | - | - |
ZL-2306(Niraparib） | Phase 2 | Ovarian Cancer | - | - |
ZL-3101 | Phase 2 | Eczema | - | - |
Brivanib 800 mg, QD | Phase 2 | Hepatocellular Carcinoma (HCC) | - | - |
ZL-1102 1% w/w gel BID for 16 weeks | Phase 2 | Plaque Psoriasis | - | - |
Ripretinib | Phase 2 | Gastrointestinal Stromal Tumor(GIST) | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Zai Lab Limited's drug pipeline?→
CatalystAlert tracks 10 drug candidates in Zai Lab Limited's (ZLAB) pipeline across Phase 3, Phase 2. Its lead program is ZL-1310 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Zai Lab Limited's next FDA catalyst?→
Zai Lab Limited's (ZLAB) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ZLAB biotech catalysts?→
Add ZLAB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Zai Lab Limited's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.